Synthesis, docking study, and structure-activity relationship of novel niflumic acid derivatives acting as anticancer agents by inhibiting VEGFR or EGFR tyrosine kinase activities


	Flow cytometric analysis of cell cycle phases in control and compound 4C-treated Hep G2 hepatocyte carcinoma cells. Hep G2 Cells were treated with 4.62 µM (IC50 value) of compound 4C for 48 h, stained with PI and subjected to flow cytometry.

Part of: Yaseen Y, Kubba A, Shihab W, Tahtamouni L (2022) Synthesis, docking study, and structure-activity relationship of novel niflumic acid derivatives acting as anticancer agents by inhibiting VEGFR or EGFR tyrosine kinase activities. Pharmacia 69(3): 595-614. https://doi.org/10.3897/pharmacia.69.e86504